MARK KIRSCHBAUM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2023-11-14 Dr. Mark Kirschbaum(2) ... Includes options to purchase 5,556 shares of Common Stock...

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04